Your browser doesn't support javascript.
loading
Monoamine Oxidase A Gene Methylation and Its Role in Posttraumatic Stress Disorder: First Evidence from the South Eastern Europe (SEE)-PTSD Study.
Ziegler, Christiane; Wolf, Christiane; Schiele, Miriam A; Feric Bojic, Elma; Kucukalic, Sabina; Sabic Dzananovic, Emina; Goci Uka, Aferdita; Hoxha, Blerina; Haxhibeqiri, Valdete; Haxhibeqiri, Shpend; Kravic, Nermina; Muminovic Umihanic, Mirnesa; Cima Franc, Ana; Jaksic, Nenad; Babic, Romana; Pavlovic, Marko; Warrings, Bodo; Bravo Mehmedbasic, Alma; Rudan, Dusko; Aukst-Margetic, Branka; Kucukalic, Abdulah; Marjanovic, Damir; Babic, Dragan; Bozina, Nada; Jakovljevic, Miro; Sinanovic, Osman; Avdibegovic, Esmina; Agani, Ferid; Dzubur-Kulenovic, Alma; Deckert, Jürgen; Domschke, Katharina.
Afiliación
  • Ziegler C; Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
  • Wolf C; Department of Psychiatry, Psychosomatics and Psychotherapy, University of Würzburg, Würzburg, Germany.
  • Schiele MA; Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
  • Feric Bojic E; Department of Genetics and Bioengineering, International Burch University, Sarajevo, Bosnia and Herzegovina.
  • Kucukalic S; Department of Psychiatry, University Clinical Center, Sarajevo, Bosnia and Herzegovina.
  • Sabic Dzananovic E; Department of Psychiatry, University Clinical Center, Sarajevo, Bosnia and Herzegovina.
  • Goci Uka A; Department of Psychiatry, University Clinical Center of Kosovo, Prishtina, Kosovo.
  • Hoxha B; Department of Psychiatry, University Clinical Center of Kosovo, Prishtina, Kosovo.
  • Haxhibeqiri V; Department of Medical Biochemistry, University Clinical Center of Kosovo, Prishtina, Kosovo.
  • Haxhibeqiri S; Institute of Kosovo Forensic Psychiatry, University Clinical Center of Kosovo, Prishtina, Kosovo.
  • Muminovic Umihanic M; Department of Psychiatry, University Clinical Center of Tuzla, Tuzla, Bosnia and Herzegovina.
  • Cima Franc A; Community Health Center, Zivinice, Bosnia and Herzegovina.
  • Jaksic N; Department of Psychiatry, University Hospital Center Zagreb, Zagreb, Croatia.
  • Babic R; Department of Psychiatry, University Hospital Center Zagreb, Zagreb, Croatia.
  • Pavlovic M; Department of Psychiatry, University Clinical Center of Mostar, Mostar, Bosnia and Herzegovina.
  • Warrings B; Department of Psychiatry, University Clinical Center of Mostar, Mostar, Bosnia and Herzegovina.
  • Bravo Mehmedbasic A; Department of Psychiatry, Psychosomatics and Psychotherapy, University of Würzburg, Würzburg, Germany.
  • Rudan D; Department of Psychiatry, University Clinical Center, Sarajevo, Bosnia and Herzegovina.
  • Aukst-Margetic B; Department of Psychiatry, University Hospital Center Zagreb, Zagreb, Croatia.
  • Kucukalic A; Department of Psychiatry, University Hospital Sestre Milosrdnice, Zagreb, Croatia.
  • Marjanovic D; Department of Psychiatry, University Clinical Center, Sarajevo, Bosnia and Herzegovina.
  • Babic D; Department of Genetics and Bioengineering, International Burch University, Sarajevo, Bosnia and Herzegovina.
  • Bozina N; Institute for Anthropological Researches, Zagreb, Croatia.
  • Jakovljevic M; Department of Psychiatry, University Clinical Center of Mostar, Mostar, Bosnia and Herzegovina.
  • Sinanovic O; Department of Laboratory Diagnostics, University Hospital Center Zagreb, Zagreb, Croatia.
  • Avdibegovic E; Department of Psychiatry, University Hospital Center Zagreb, Zagreb, Croatia.
  • Agani F; Department of Neurology, University Clinical Center of Tuzla, Tuzla, Bosnia and Herzegovina.
  • Dzubur-Kulenovic A; Department of Psychiatry, University Clinical Center of Tuzla, Tuzla, Bosnia and Herzegovina.
  • Deckert J; Faculty of Medicine, University Hasan Prishtina, Prishtina, Kosovo.
  • Domschke K; Department of Psychiatry, University Clinical Center, Sarajevo, Bosnia and Herzegovina.
Int J Neuropsychopharmacol ; 21(5): 423-432, 2018 05 01.
Article en En | MEDLINE | ID: mdl-29186431
Background: Posttraumatic stress disorder is characterized by an overactive noradrenergic system conferring core posttraumatic stress disorder symptoms such as hyperarousal and reexperiencing. Monoamine oxidase A is one of the key enzymes mediating the turnover of noradrenaline. Here, DNA methylation of the monoamine oxidase A gene exonI/intronI region was investigated for the first time regarding its role in posttraumatic stress disorder risk and severity. Methods: Monoamine oxidase A methylation was analyzed via direct sequencing of sodium bisulfite-treated DNA extracted from blood cells in a total sample of N=652 (441 male) patients with current posttraumatic stress disorder, patients with remitted posttraumatic stress disorder, and healthy probands (comparison group) recruited at 5 centers in Bosnia-Herzegovina, Croatia, and the Republic of Kosovo. Posttraumatic stress disorder severity was measured by means of the Clinician-Administered Posttraumatic Stress Disorder Scale and its respective subscores representing distinct symptom clusters. Results: In the male, but not the female sample, patients with current posttraumatic stress disorder displayed hypermethylation of 3 CpGs (CpG3=43656362; CpG12=43656514; CpG13=43656553, GRCh38.p2 Assembly) as compared with remitted Posttraumatic Stress Disorder patients and healthy probands. Symptom severity (Clinician-Administered Posttraumatic Stress Disorder Scale scores) in male patients with current posttraumatic stress disorder significantly correlated with monoamine oxidase A methylation. This applied particularly to symptom clusters related to reexperiencing of trauma (cluster B) and hyperarousal (cluster D). Conclusions: The present findings suggest monoamine oxidase A gene hypermethylation, potentially resulting in enhanced noradrenergic signalling, as a disease status and severity marker of current posttraumatic stress disorder in males. If replicated, monoamine oxidase A hypermethylation might serve as a surrogate marker of a hyperadrenergic subtype of posttraumatic stress disorder guiding personalized treatment decisions on the use of antiadrenergic agents.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_geracao_evidencia_conhecimento Asunto principal: Trastornos por Estrés Postraumático / Metilación de ADN / Epigénesis Genética / Monoaminooxidasa Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Int J Neuropsychopharmacol Asunto de la revista: NEUROLOGIA / PSICOFARMACOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_geracao_evidencia_conhecimento Asunto principal: Trastornos por Estrés Postraumático / Metilación de ADN / Epigénesis Genética / Monoaminooxidasa Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Int J Neuropsychopharmacol Asunto de la revista: NEUROLOGIA / PSICOFARMACOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Alemania
...